The benefits of dedicated Biocompatible UHPLC and chromatography column for analysis of Biomolecules

RECORD | Already taken place Fr, 22.1.2021

This webcast will showcase the challenges analytical laboratories face when analyzing biotherapeutics and how the hurdles of compromised sample integrity and surface interaction may be overcome.

Go to the webinar

Agilent Technologies: The benefits of dedicated Biocompatible UHPLC and chromatography column for analysis of Biomolecules

High performance liquid chromatography with optical detection or coupled to mass spectrometry are fundamental methods characterization and quality control of biopharmaceutical products. Biotherapeutic molecules represent a versatile class of compounds that need special attention for sample preparation, LC instrumentation, and type of chromatography columns used.

Presenter: Manu Grover (Business Manager, Agilent Technologies, India)

Presenter: Vinayak AK (Product Specialist, Agilent Technologies, India)

Presenter: Cornelia Vad (Senior Product Manager Analytical HPLC, Agilent Technologies)

Presenter: Dr. Andrew Coffey (Senior Applications Chemist, Agilent Technologies)

Agilent Technologies

The benefits of dedicated Biocompatible UHPLC and chromatography column for analysis of Biomolecules

Related content

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Out-of-the-box workflow for PFAS quantitation using a fullscan high-resolution approach with the Orbitrap Exploris EFOX Mass Detector